Published in Circulation on August 12, 2014
RhoA/mDia-1/profilin-1 signaling targets microvascular endothelial dysfunction in diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol (2015) 0.82
Overexpression of Cardiomyocyte α1A-Adrenergic Receptors Attenuates Postinfarct Remodeling by Inducing Angiogenesis Through Heterocellular Signaling. Arterioscler Thromb Vasc Biol (2015) 0.80
Endothelial cell control of thrombosis. BMC Cardiovasc Disord (2015) 0.80
Novel hydroxybutyl chitosan nanoparticles for siRNA delivery targeting tissue factor inhibits proliferation and induces apoptosis in human vascular smooth muscle cells. Mol Med Rep (2015) 0.78
Nestin(+) cells direct inflammatory cell migration in atherosclerosis. Nat Commun (2016) 0.76
Abnormalities in Alternative Splicing of Apoptotic Genes and Cardiovascular Diseases. Int J Mol Sci (2015) 0.75
Targeting CITED2 for Angiogenesis in Obesity and Insulin Resistance. Diabetes (2016) 0.75
Impact of thrombosis on pulmonary endothelial injury and repair following sepsis. Am J Physiol Lung Cell Mol Physiol (2017) 0.75
Vascular Endothelial Growth Factor Gene Polymorphism (rs2010963) and Its Receptor, Kinase Insert Domain-Containing Receptor Gene Polymorphism (rs2071559), and Markers of Carotid Atherosclerosis in Patients with Type 2 Diabetes Mellitus. J Diabetes Res (2015) 0.75
"Soluble Tissue Factor" in the 21st Century: Definitions, Biochemistry, and Pathophysiological Role in Thrombus Formation. Semin Thromb Hemost (2015) 0.75
Macrophage-derived foam cells impair endothelial barrier function by inducing endothelial-mesenchymal transition via CCL-4. Int J Mol Med (2017) 0.75
Biological relevance of tissue factor and IL-6 in arteriovenous malformations. Neurosurg Rev (2016) 0.75
Angiogenesis in health and disease. Nat Med (2003) 14.02
Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2010) 9.18
Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates. J Am Coll Cardiol (2007) 7.13
The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med (1992) 6.41
Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med (2003) 5.43
HIF-1: upstream and downstream of cancer metabolism. Curr Opin Genet Dev (2009) 5.24
Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med (1997) 5.09
Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins. Nat Med (2002) 4.87
A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol (1995) 4.43
Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol (2005) 4.29
Hydroxylation of HIF-1: oxygen sensing at the molecular level. Physiology (Bethesda) (2004) 3.79
Signal transduction to hypoxia-inducible factor 1. Biochem Pharmacol (2002) 3.73
Integrin signaling and cell growth control. Curr Opin Cell Biol (1998) 3.32
The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N Engl J Med (1992) 3.16
Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nat Med (2003) 2.93
Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation (1994) 2.77
Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford plaque study. Circulation (2006) 2.53
The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy, and policy issues: a report from the American College of Cardiology. J Am Coll Cardiol (2012) 2.44
Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability. Circulation (2004) 2.30
Elimination of neoangiogenesis for plaque stabilization: is there a role for local drug therapy? J Am Coll Cardiol (2007) 1.78
Signaling of the tissue factor coagulation pathway in angiogenesis and cancer. Arterioscler Thromb Vasc Biol (2005) 1.78
Expression of lipoprotein-associated phospholipase A(2) in carotid artery plaques predicts long-term cardiac outcome. Eur Heart J (2009) 1.77
Carotid rupture and intraplaque hemorrhage: immunophenotype and role of cells involved. Am Heart J (1998) 1.77
Tumor angiogenesis and tissue factor. Nat Med (1996) 1.58
Vascular endothelial growth factor regulates reendothelialization and neointima formation in a mouse model of arterial injury. Circulation (2004) 1.45
Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity. Circulation (2003) 1.42
Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation (1997) 1.39
Endothelial FAK is required for tumour angiogenesis. EMBO Mol Med (2010) 1.38
Alternatively spliced tissue factor induces angiogenesis through integrin ligation. Proc Natl Acad Sci U S A (2009) 1.35
The role of monocytes in angiogenesis and atherosclerosis. J Am Coll Cardiol (2013) 1.32
Dysregulation of the ubiquitin-proteasome system in human carotid atherosclerosis. Arterioscler Thromb Vasc Biol (2006) 1.25
Focal adhesion kinase and tumour angiogenesis. J Pathol (2011) 1.23
Tissue factor and cell signalling in cancer progression and thrombosis. J Thromb Haemost (2011) 1.20
Alphavbeta3/alphavbeta5 integrins-FAK-RhoB: a novel pathway for hypoxia regulation in glioblastoma. Cancer Res (2009) 1.20
Alternatively spliced human tissue factor promotes tumor growth and angiogenesis in a pancreatic cancer tumor model. Thromb Res (2007) 1.20
Assessment of plasma tissue factor activity in patients presenting with coronary artery disease: limitations of a commercial assay. J Thromb Haemost (2009) 1.16
Tissue factor in cancer progression and angiogenesis. Thromb Res (2010) 1.10
Splice variants of tissue factor promote monocyte-endothelial interactions by triggering the expression of cell adhesion molecules via integrin-mediated signaling. J Thromb Haemost (2011) 1.05
Expression of tissue factor in pancreatic adenocarcinoma is associated with activation of coagulation. World J Gastroenterol (2006) 1.04
Imaging of the vasa vasorum. Nat Clin Pract Cardiovasc Med (2008) 1.01
Antagonistic roles of four SR proteins in the biosynthesis of alternatively spliced tissue factor transcripts in monocytic cells. J Leukoc Biol (2009) 0.96
Identification of a novel human tissue factor splice variant that is upregulated in tumor cells. Int J Cancer (2006) 0.92
Alternatively spliced tissue factor. A crippled protein in coagulation or a key player in non-haemostatic processes? Hamostaseologie (2010) 0.89
Atherosclerosis in mice is not affected by a reduction in tissue factor expression. Arterioscler Thromb Vasc Biol (2005) 0.87
Pathology of unstable plaque: correlation with the clinical severity of acute coronary syndromes. J Am Coll Cardiol (1997) 0.87
Role of alternatively spliced tissue factor in pancreatic cancer growth and angiogenesis. Semin Thromb Hemost (2008) 0.87
Prostanoid and TP-receptors in atherothrombosis: is there a role for their antagonism? Thromb Haemost (2010) 0.86
Tumor expression of alternatively spliced tissue factor is a prognostic marker in non-small cell lung cancer. J Thromb Haemost (2009) 0.83
Synergistic role of protein phosphatase inhibitor 1 and sarco/endoplasmic reticulum Ca2+ -ATPase in the acquisition of the contractile phenotype of arterial smooth muscle cells. Circulation (2013) 0.81
DNA repair: Cyclin D1 multitasks. Nature (2011) 0.79